The Blood Cancer Discovery editors proudly present this collection of impactful myeloma articles that have been published in the Journal. Blood Cancer Discovery Editorial Office American Association for Cancer Research | Publications Division 615…
AbstractPurpose:. B-cell maturation antigen (BCMA)-chimeric antigen receptor T-cells (CART) improve results obtained with conventional therapy in the treatment of relapsed/refractory multiple myeloma. However, the high…
Dirigido a: Médicos, fundamentalmente hematólogos, nefrólogos e internistas, implicados en el diagnóstico y tratamiento de pacientes afectos de amiloidosis y/o mieloma múltiple. Aunque el curso…
The Blood Cancer Discovery editors proudly present this collection of impactful myeloma articles that have been published in the Journal.
La Universidad de Barcelona dispone una nueva cátedra la Cátedra UB AMGEN de Mieloma Múltiple
L’esdeveniment “The Physician-Scientist Career Chronicles: From MD to PhD” està organitzat pel Centre de Regulació Genòmica (CRG) i l’Institut d’Investigacions Biomèdiques August Pi i Sunyer…
B-cell maturation antigen (BCMA) is the lead antigen for CAR T-cell therapy in multiple myeloma (MM). A challenge is inter- and intra-patient heterogeneity in BCMA…
El IDIBAPS impulsa varios programas para facilitar que profesionales asistenciales compaginen la atención a los enfermos con la investigación biomédica o disfruten de períodos de…
The collection showcases recent advances published in Blood Cancer Discovery on immunotherapy. This research holds promise to enhance clinical benefit
